GLYCOMINDS

Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
GLYCOMINDS
Industry:
Biotechnology Health Diagnostics
Founded:
1999-01-01
Address:
Lod, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.glycominds.com
Total Employee:
11+
Status:
Closed
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google Google Cloud Sectigo SSL Sectigo Domain SSL
Current Employees Featured
Investors List
BRM Capital
BRM Capital investment in Venture Round - Glycominds
Millennium II Materials Technology Fund
Millennium II Materials Technology Fund investment in Venture Round - Glycominds
Official Site Inspections
http://www.glycominds.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
Loading ... 
